High Court’s Vaccines Ruling Gives Drug Makers Hope For Design Defect Claim Pre-emption
Executive Summary
The U.S. Supreme Court’s ruling that vaccine design defect claims are statutorily pre-empted could provide a potential defense in certain pharmaceutical product liability lawsuits, industry attorneys said.